|Articles|May 8, 2023
Camber Pharmaceuticals Launches Generic Syprine
Advertisement
Camber Pharmaceuticals is pleased to announce the addition of Trientine Hydrochloride Capsules, USP to its current portfolio.
Trientine Hydrochloride Capsules, USP are indicated in the treatment of patients with Wilson's disease who are intolerant of penicillamine.
Trientine Hydrochloride Capsules, USP are available in 250 mg strength in 100 count bottles.
To find out more about Trientine Hydrochloride Capsules, USP please visit
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dosage manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers, improving quality of life through cost-effective medications.
SOURCE: Camber Pharmaceuticals
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
2
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
3
Expert Discusses Early Safety and Tolerability Findings for VMT-α-NET in Neuroendocrine Tumors | ESMO 2025
4
TAR-200 Intravesical System Demonstrates Sustained Bladder Exposure in BCG-Unresponsive NMIBC
5
